Is It Too Late to Buy Iovance Biotherapeutics Stock?

Earlier this year, share prices of Iovance Biotherapeutics (IOVA -1.23%) were soaring after one of its therapies obtained approval from regulators. Iovance stock would go on to reach share price highs of more than $18. Today, however, the stock trades at less than half that price. And in just three months, it has fallen by more than 40% as the hype surrounding the business appears to have evaporated. On Feb. 16, the Food and Drug Administration (FDA) granted accelerated approval for Iovance's cell therapy t ...